Eine Kamera ist auf eine reflektierende Glasscheibe gerichtet.
© DZIF

News

All current DZIF news can be found here.

Yannic Bartsch, Anke Kraft, Markus Cornberg
© CiiM

Towards the functional cure of hepatitis B

A recent study from Hannover, in which the German Center for Infection Research (DZIF) is also involved, provides important insights into the understanding and future treatment of chronic hepatitis B

Fertility Clinic UKSH, Campus Lübeck
© UKSH

Artificial insemination: A combination of bacteria could predict success, current tests lack a scientific basis

Common tests designed to predict the success of artificial insemination are often inaccurate. This conclusion is drawn from a new study conducted by the University Hospital Schleswig-Holstein (UKSH)

Processing of sputum samples for the culture of Mycobacterium tuberculosis and drug-resistance testing in the tuberculosis lab in Riga.
© Christoph Lange

Long-term cure rates for multidrug-resistant tuberculosis much better than expected

A new national cohort study from Latvia, conducted in collaboration with researchers from the clinical tuberculosis infrastructure (ClinTB) at the German Center for Infection Research (DZIF) at the

This illustration depicts a three-dimensional (3D) computer-generated image of a cluster of paired, or diplococcal, vancomycin-resistant Enterococcus (VRE) bacteria.
© CDC / Dan Higgins-Medical Illustrator

Development of a rapid test for diagnosing hard-to-treat VRE bacteria

Enterococcus faecium is a bacterium that is naturally resistant to many common antibiotics. Particularly in vulnerable patient groups, such as immunocompromised individuals, the bacterium can cause

Produced by the National Institute of Allergy and Infectious Diseases (NIAID), this digitally colorized scanning electron microscopic (SEM) image, depicts a large group of orange-colored, rod shaped, Mycobacterium tuberculosis bacteria, which cause tuberculosis (TB) in human beings.
© National Institute of Allergy and Infectious Diseases (NIAID)

New S3 guideline on tuberculosis prevention among new migrants published

Just in time for today’s World Tuberculosis Day, the new S3 guideline on tuberculosis prevention among newly arrived migrants has gone online at the Association of Scientific Medical Societies (AWMF)

Prof. Lange (center) receives the Oskar-Medical-Prize
© Mike Auerbach

Prof. Christoph Lange awarded the 2025 Oskar Medical Prize

Prof. Christoph Lange, Head of the Clinical Tuberculosis Infrastructure at the German Center for Infection Research (DZIF) and Medical Director of the Borstel Research Center, Leibniz Lung Center, has

The GUARDIAN project uses AI to combat antibiotic-resistant bacteria.
© JLU (Generated by AI using ChatGPT)

Kickoff meeting for the GUARDIAN research project in Giessen marks the launch of interdisciplinary collaboration against antibiotic resistance

At the DZIF partner site in Giessen, a ceremonial kickoff meeting marked the launch of the GUARDIAN research project, which is funded with 3.5 million euros by the Federal Ministry of Research

Model of a hepatitis E virus particle
© RUB, Marquard

Promising active substance against hepatitis E identified

Around 70,000 people die each year from infections with the hepatitis E virus. There is currently neither a vaccine nor a specific drug against this virus. This could change with the identification of

Symbolic photo, lab work
© Vic Josh/adobe.stock.com

Innovation in tuberculosis treatment: New international study launched

The Institute of Infectious Diseases and Tropical Medicine has announced the inclusion of the first study participant in the STEP2C Stage 3 trial. The study is part of the international UNITE4TB

Seven people standing in a laboratory room next to a large metal device, with pipes, ducts, and technical equipment visible in the background.
© DZIF

Close collaboration between the Helmholtz Munich Biobank and the DZIF Transplant Cohort

The DZIF Transplant Cohort (Tx Cohort) provides interested researchers and study groups with extensive medical data on over 3,000 transplant recipients, focusing on infections. The cohort data is